Abstract
During the lifetime, our cells encounter many challenges to their own existence. The survival of organisms and cells depends on the interplay within a complex, yet precisely orchestrated network of proteins. Since the discovery of the Rel/NF-κB family of transcription factors, the research has never come to a stop. These proteins are best known for their key roles played in normal immune and inflammatory responses, also in the control of cellular proliferation, differentiation, apoptosis and oncogenesis. The recent years have witnessed an emerging research regarding NF-κB signalling pathways in aging and senescence as well. In this review we go deeply through NF-κB activity in the modern biogerontology, with the arguments around its possible roles in aging. Nevertheless, a detailed molecular action and mechanism of NF-κB regulation during senescence has yet to be determined. Elucidation of the exact role of NF-κB in aging will be crucial for developing new therapeutic strategies.
Keywords: NF-κB, activation cascades, aging, SNARK, mTOR, sirtuins
Current Drug Metabolism
Title: NF-κB Signature on the Aging Wall
Volume: 11 Issue: 3
Author(s): Doaa Hussein Zineldeen, Hiroaki Uranishi and Takashi Okamoto
Affiliation:
Keywords: NF-κB, activation cascades, aging, SNARK, mTOR, sirtuins
Abstract: During the lifetime, our cells encounter many challenges to their own existence. The survival of organisms and cells depends on the interplay within a complex, yet precisely orchestrated network of proteins. Since the discovery of the Rel/NF-κB family of transcription factors, the research has never come to a stop. These proteins are best known for their key roles played in normal immune and inflammatory responses, also in the control of cellular proliferation, differentiation, apoptosis and oncogenesis. The recent years have witnessed an emerging research regarding NF-κB signalling pathways in aging and senescence as well. In this review we go deeply through NF-κB activity in the modern biogerontology, with the arguments around its possible roles in aging. Nevertheless, a detailed molecular action and mechanism of NF-κB regulation during senescence has yet to be determined. Elucidation of the exact role of NF-κB in aging will be crucial for developing new therapeutic strategies.
Export Options
About this article
Cite this article as:
Hussein Zineldeen Doaa, Uranishi Hiroaki and Okamoto Takashi, NF-κB Signature on the Aging Wall, Current Drug Metabolism 2010; 11 (3) . https://dx.doi.org/10.2174/138920010791196283
DOI https://dx.doi.org/10.2174/138920010791196283 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extracellular ATP and Neurodegeneration
Current Drug Targets - CNS & Neurological Disorders Metabolism and Toxicological Implications of Commonly Used Chemopreventive Drugs Against Breast Cancer/Carcinogenesis
Current Drug Metabolism Natural Products on Nonalcoholic Fatty Liver Disease
Current Drug Targets Editorial (Thematic Issue: Proteomic Signatures for Cancer Personalized Medicine)
Current Proteomics Prevention and Treatment of Bone Metastases
Current Pharmaceutical Design Novel Functions of MicroRNA-17-92 Cluster in the Endocrine System
Current Drug Targets Nutrigenomics and Its Approaches for Control of Chronic Diseases
Current Biotechnology The Relationship Between Lithium and Cancer Proliferation: A Case-Based Review of the Literature
Current Drug Metabolism Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Mechanistic Overview of Immune Modulatory Effects of Environmental Toxicants
Inflammation & Allergy - Drug Targets (Discontinued) C-11 Radiochemistry in Cancer Imaging Applications
Current Topics in Medicinal Chemistry Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies
Current Clinical Pharmacology Vascular Endothelial Growth Factor: A New Paradigm for Targeting Various Diseases
Current Angiogenesis (Discontinued) 12-Lipoxygenase: A Potential Target for Novel Anti-Platelet Therapeutics
Cardiovascular & Hematological Agents in Medicinal Chemistry Human Exposure to Endocrine Disruptors and Breast Milk
Endocrine, Metabolic & Immune Disorders - Drug Targets Effectiveness of Antiviral and Immunomodulatory Agents in the Treatment of COVID-19: A Systematic Review
Current Respiratory Medicine Reviews Gymnema sylvestre R. Br., an Indian Medicinal Herb: Traditional Uses, Chemical Composition, and Biological Activity
Current Pharmaceutical Biotechnology Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction
CNS & Neurological Disorders - Drug Targets Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
Current Molecular Medicine Growth Restriction: Etiology, Maternal and Neonatal Outcome. A Review
Current Women`s Health Reviews